Cite
Barnell EK, Newcomer KF, Skidmore ZL, et al. Impact of a 40-Gene Targeted Panel Test on Physician Decision Making for Patients With Acute Myeloid Leukemia. JCO Precis Oncol. 2021;5doi: 10.1200/PO.20.00182.
Barnell, E. K., Newcomer, K. F., Skidmore, Z. L., Krysiak, K., Anderson, S. R., Wartman, L. D., Oh, S. T., Welch, J. S., Stockerl-Goldstein, K. E., Vij, R., Cashen, A. F., Pusic, I., Westervelt, P., Abboud, C. N., Ghobadi, A., Uy, G. L., Schroeder, M. A., Dipersio, J. F., Politi, M. C., Spencer, D. H., Duncavage, E. J., Ley, T. J., Griffith, M., Jacoby, M. A., & Griffith, O. L. (2021). Impact of a 40-Gene Targeted Panel Test on Physician Decision Making for Patients With Acute Myeloid Leukemia. JCO precision oncology, 5. https://doi.org/10.1200/PO.20.00182
Barnell, Erica K, et al. "Impact of a 40-Gene Targeted Panel Test on Physician Decision Making for Patients With Acute Myeloid Leukemia." JCO precision oncology vol. 5 (2021). doi: https://doi.org/10.1200/PO.20.00182
Barnell EK, Newcomer KF, Skidmore ZL, Krysiak K, Anderson SR, Wartman LD, Oh ST, Welch JS, Stockerl-Goldstein KE, Vij R, Cashen AF, Pusic I, Westervelt P, Abboud CN, Ghobadi A, Uy GL, Schroeder MA, Dipersio JF, Politi MC, Spencer DH, Duncavage EJ, Ley TJ, Griffith M, Jacoby MA, Griffith OL. Impact of a 40-Gene Targeted Panel Test on Physician Decision Making for Patients With Acute Myeloid Leukemia. JCO Precis Oncol. 2021 Jan 14;5. doi: 10.1200/PO.20.00182. eCollection 2021. PMID: 34036230; PMCID: PMC8140802.
Copy
Download .nbib